IL17A and neoplasm: Although beyond this biomarker discovery study, future work should integrate spatial transcriptomics/multiplex IHC to map microbial niches, metabolite gradients, and immune infiltrates (e.g., PD-1+ TILs, IL-17 levels) in resection specimens-this may elucidate how microbial metabolites locally modulate anti-tumor immunity.